Abstract
C-terminal binding protein 1 (CtBP1) is a transcriptional co-repressor and metabolic sensory protein, which often represses tumor suppressor genes. Hence, we sought to determine if CtBP1 affects expression of the tumor suppressor Brca1 in head and neck tissue, as downregulation of Brca1 begins at the early stages of head and neck squamous cell carcinomas (HNSCCs). We found that CtBP1 represses Brca1 transcription by binding to the E2F4 site of the Brca1 promoter. Additionally, the recruitment of CtBP1 to the Brca1 promoter is redox-dependent, that is, increased at high NADH levels in hypoxic conditions. Further, immunostaining using a human HNSCC tissue array revealed that nuclear CtBP1 staining began to accumulate in hyperplasic lesions and HNSCCs, this staining correlated with Brca1 downregulation in these lesions. Pharmacological disruption of CtBP1 binding to Brca1 promoter by the antioxidant Tempol, which reduces NADH levels, relieved CtBP1-mediated repression of Brca1, leading to increased DNA repair in HNSCC cells. As tumor cells are generally hypoxic with increased NADH levels, the dynamic control of Brca1 by a âmetabolic switchâ found in this study not only provides an important link between tumor metabolism and tumor suppressor expression but also suggests a potential chemo preventative or therapeutic strategy for HNSCC by blocking NADH-dependent CtBP1 activity at early stages of HNSCC carcinogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andres JL, Fan S, Turkel GJ, Wang JA, Twu NF, Yuan RQ et al. (1998). Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene 16: 2229â2241.
Atlas E, Stramwasser M, Mueller CR . (2001). A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element. Oncogene 20: 7110â7114.
Baker KM, Wei G, Schaffner AE, Ostrowski MC . (2003). Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter. J Biol Chem 278: 17876â17884.
Barnes CJ, Vadlamudi RK, Mishra SK, Jacobson RH, Li F, Kumar R . (2003). Functional inactivation of a transcriptional corepressor by a signaling kinase. Nat Struct Biol 10: 622â628.
Berton TR, Matsumoto T, Page A, Conti CJ, Deng CX, Jorcano JL et al. (2003). Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues. Oncogene 22: 5415â5426.
Bindra RS, Gibson SL, Meng A, Westermark U, Jasin M, Pierce AJ et al. (2005). Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res 65: 11597â11604.
Bindra RS, Glazer PM . (2006). Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites. Cancer Biol Ther 5: 1400â1407.
Bornstein S, White R, Malkoski S, Oka M, Han G, Cleaver T et al. (2009). Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J Clin Invest 119: 3408â3419.
Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S, Chinnadurai G . (1993). A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J 12: 469â478.
Chinnadurai G . (2002). CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell 9: 213â224.
Chinnadurai G . (2009). The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res 69: 731â734.
D'Andrea AD, Grompe M . (2003). The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 3: 23â34.
De Siervi A, De Luca P, Byun JS, Di LJ, Fufa T, Haggerty CM et al. (2010). Transcriptional autoregulation by BRCA1. Cancer Res 70: 532â542.
Erker L, Schubert R, Yakushiji H, Barlow C, Larson D, Mitchell JB et al. (2005). Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor. Hum Mol Genet 14: 1699â1708.
Fjeld CC, Birdsong WT, Goodman RH . (2003). Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc Natl Acad Sci USA 100: 9202â9207.
Forastiere A, Koch W, Trotti A, Sidransky D . (2001). Head and neck cancer. N Engl J Med 345: 1890â1900.
Grooteclaes ML, Frisch SM . (2000). Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19: 3823â3828.
Hunter KD, Parkinson EK, Harrison PR . (2005). Profiling early head and neck cancer. Nat Rev Cancer 5: 127â135.
Iannone A, Tomasi A, Vannini V, Swartz HM . (1990). Metabolism of nitroxide spin labels in subcellular fraction of rat liver. I. reduction by microsomes. Biochim Biophys Acta 1034: 285â289.
Kim JH, Cho EJ, Kim ST, Youn HD . (2005). CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain. Nat Struct Mol Biol 12: 423â428.
Kim JH, Youn HD . (2009). C-terminal binding protein maintains mitochondrial activities. Cell Death Differ 16: 584â592.
Krishna MC, Grahame DA, Samuni A, Mitchell JB, Russo A . (1992). Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci USA 89: 5537â5541.
Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG et al. (2003). High incidence of head and neck squamous cell carcinoma in patients with fanconi anemia. Arch Otolaryngol Head Neck Surg 129: 106â112.
Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT . (2004). Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 23: 1000â1004.
Meloni AR, Smith EJ, Nevins JR . (1999). A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor. Proc Natl Acad Sci USA 96: 9574â9579.
Metz JM, Smith D, Mick R, Lustig R, Mitchell J, Cherakuri M et al. (2004). A phase I study of topical tempol for the prevention of alopecia induced by whole brain radiotherapy. Clin Cancer Res 10: 6411â6417.
Mirnezami AH, Campbell SJ, Darley M, Primrose JN, Johnson PW, Blaydes JP . (2003). Hdm2 recruits a hypoxia-sensitive corepressor to negatively regulate p53-dependent transcription. Curr Biol 13: 1234â1239.
Mitchell JB, Xavier S, DeLuca AM, Sowers AL, Cook JA, Krishna MC et al. (2003). A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic Biol Med 34: 93â102.
Mueller CR, Roskelley CD . (2003). Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res 5: 45â52.
Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G . (1995). Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci USA 92: 10467â10471.
Schubert R, Erker L, Barlow C, Yakushiji H, Larson D, Russo A et al. (2004). Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum Mol Genet 13: 1793â1802.
Shen SX, Weaver Z, Xu X, Li C, Weinstein M, Chen L et al. (1998). A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17: 3115â3124.
Sparano A, Quesnelle KM, Kumar MS, Wang Y, Sylvester AJ, Feldman M et al. (2006). Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope 116: 735â741.
Subramanian T, La Regina M, Chinnadurai G . (1989). Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. Oncogene 4: 415â420.
Thakur S, Croce CM . (1999). Positive regulation of the BRCA1 promoter. J Biol Chem 274: 8837â8843.
Weber F, Xu Y, Zhang L, Patocs A, Shen L, Platzer P et al. (2007). Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. Jama 297: 187â195.
Williamson DH, Lund P, Krebs HA . (1967). The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 103: 514â527.
Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ . (2007). Downregulation of fanconi anemia genes in sporadic head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 69: 218â225.
Wu W, Platoshyn O, Firth AL, Yuan JX . (2007). Hypoxia divergently regulates production of reactive oxygen species in human pulmonary and coronary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 293: L952â959.
Zhang Q, Piston DW, Goodman RH . (2002). Regulation of corepressor function by nuclear NADH. Science 295: 1895â1897.
Zhang Q, Wang SY, Fleuriel C, Leprince D, Rocheleau JV, Piston DW et al. (2007). Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc Natl Acad Sci USA 104: 829â833.
Zhang Q, Wang SY, Nottke AC, Rocheleau JV, Piston DW, Goodman RH . (2006). Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc Natl Acad Sci USA 103: 9029â9033.
Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH . (2003). Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 115: 177â186.
Zhang QS, Eaton L, Snyder ER, Houghtaling S, Mitchell JB, Finegold M et al. (2008). Tempol protects against oxidative damage and delays epithelial tumor onset in fanconi anemia mice. Cancer Res 68: 1601â1608.
Acknowledgements
This work was supported by Grants from the NIH, R01DE15953 (to X-JW) and R01CA115468 (to QZ). We thank Dr Petra Boukamp for providing the normal human keratinocytes HaCaT cells and Dr James Mitchell for helpful discussions.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Deng, Y., Liu, J., Han, G. et al. Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1. Oncogene 29, 6603â6608 (2010). https://doi.org/10.1038/onc.2010.406
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.406
Keywords
This article is cited by
-
The deubiquitinating enzyme USP4 regulates BRCA1 stability and function
npj Breast Cancer (2024)
-
NADH elevation during chronic hypoxia leads to VHL-mediated HIF-1α degradation via SIRT1 inhibition
Cell & Bioscience (2023)
-
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
Oncogenesis (2023)
-
C-terminal of E1A binding protein 2 promotes the malignancy of osteosarcoma cells via JAK1/Stat3 signaling
Journal of Cell Communication and Signaling (2020)
-
Epigenetic re-wiring of breast cancer by pharmacological targeting of C-terminal binding protein
Cell Death & Disease (2019)